PLYX Earnings Polaryx Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–4 of 4
| Q1 2026 | 2026-03-31 | -0.05 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -0.20 | 2026-03-24 | 10-K |
| Q1 2026 | 2025-03-31 | -0.11 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -0.89 | 2026-03-24 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.